-
大肠癌包括结肠癌和直肠癌,是威胁人类生命和健康的常见消化道恶性肿瘤,已成为我国发病率增长速度最快、发病年龄逐渐年轻化的肿瘤,目前已被列为我国恶性肿瘤死因的第4位[1]。手术、放疗、化疗和分子靶向治疗是目前恶性肿瘤的主要治疗方法。手术治疗是治疗大肠癌的有效方法,但由于多数患者确诊时已为中晚期,或已有淋巴转移,错过了治疗时机,预后不理想,因此,放疗联合化疗是治疗晚期大肠癌的主要手段。但由于放疗对肿瘤临近正常组织的损害降低了肿瘤的治疗疗效,所以有效增加大肠癌的放疗敏感性,以减少放疗剂量,从而提升大肠癌患者的放疗效果和治愈率显得尤为重要。本研究采用人视网膜母细胞瘤Rb94基因重组腺病毒(adenovirus vector containing retinoblastoma gene 94,Ad-Rb94)转染大肠癌HT29细胞,联合γ射线照射,观察Ad-Rb94联合照射对体外大肠癌细胞生长、细胞周期和细胞凋亡的变化的影响,探讨其联合抑瘤的作用机制。
Ad-Rb94联合照射对体外人大肠癌细胞的抑瘤作用
The effect of Ad-Rb94 combined with radiation on inhibiting the growth of human colorectal cancer cells in vitro
-
摘要:
目的 探讨人视网膜母细胞瘤Rb94基因重组腺病毒载体(Ad-Rb94)联合γ射线照射对体外人大肠癌细胞生长的联合抑瘤作用及其机制。 方法 将Ad-Rb94于体外转染大肠癌HT29细胞,转染后12 h进行4 Gy 137Cs γ射线照射。实验分组为5组:对照组、β-半乳糖苷酶基因重组腺病毒载体组(Ad-lacZ组)、Ad-Rb94组、照射组和Ad-Rb94联合照射组。用噻唑蓝法检测HT29细胞的生长,用流式细胞术检测HT29细胞的细胞周期和细胞凋亡的变化。 结果 当Ad-Rb94有效转染HT29细胞后,从转染第4日开始,照射组和联合照射组细胞生长速率较对照组和Ad-lacZ组缓慢;与Ad-Rb94组和照射组相比,Ad-Rb94联合照射组细胞的生长表现出更强的抑制效应(t=15.02、17.30, P<0.01)。细胞周期结果表明,与对照组、Ad-lacZ组和Ad-Rb94组相比, 照射组大量细胞停留在G2期,各组间差异有统计学意义(t=18.65、15.23、16.38, P<0.01);但Ad-Rb94联合照射组停留在G2期细胞更多(约40%),远高于照射组(t=7.78,P<0.05)。细胞凋亡结果表明,与对照组相比,Ad-Rb94组和照射组细胞凋亡率明显增加(t=16.19、10.72,P<0.01);Ad-Rb94联合照射组细胞凋亡率最高(21%),与Ad-Rb94组和照射组相比,差异有统计学意义(t=6.17、9.25,P<0.05)。 结论 腺病毒介导的Rb94基因联合照射对大肠癌细胞的抑瘤作用具有协同效应,其机制可能是促进细胞G2期阻滞和凋亡。 -
关键词:
- 基因,视网膜母细胞瘤94 /
- 基因疗法 /
- 放射疗法 /
- 大肠肿瘤 /
- 腺病毒
Abstract:Objective To evaluate the mechanism of combined effects of recombinant adenovirus-mediated retinoblastoma gene 94(Ad-Rb94)with γ-ray radiation on inhibiting the growth of human colorectal cancer cells in vitro. Methods HT29 cells were transfected by Ad-Rb94 and irradiated by 4 Gy 137Cs γ-ray 12 h after transfection. The cohorts were divided into five groups:blank control, Ad-LacZ, Ad-Rb94, radiation and Ad-Rb94 combined with radiation. The cells growth curve of HT29 cells was detected by MTT assay. Changes of cell cycle and cell apoptosis in HT29 cells were detected by flow cytometry. Results The growth of cells treated with Ad-Rb94 or radiation alone was all inhibited when Ad-Rb94 was transfected effectively into HT29 cells. The growth of HT29 cells treated with radiation or combination of Ad-Rb94 and radiation was slower than that of blank control and Ad-lacZ at 4 d after transfection. The growth of HT29 cells treated with combination of Ad-Rb94 and radiation resulted in greater inhibition compared with that of Ad-Rb94 or radiation alone(t=15.02 and 17.30, P < 0.01). Cell cycle data showed that HT29 cells treated with radiation were arrested at G2 phase, and there were significant differences compared with that of blank control, Ad-lacZ and Ad-Rb94(t=18.65, 15.23 and 16.38, P < 0.01). Cells treated with combination of Ad-Rb94 and radiation arrested at G2 phases increasingly, reached 40%, significantly higher than that of radiation alone(t=7.78, P < 0.05). Cells apoptosis data showed that the apoptosis ratio of HT29 cells treated with Ad-Rb94 or radiation was markedly increased compared with that of blank control(t=16.19 and 10.72, P < 0.01). Cells apoptosis ratio of HT29 cells treated with combination of Ad-Rb94 and radiation was the highest, reached 21%, and there were significant differences compared with that of Ad-Rb94 or radiation alone(t=6.17 and 9.25, P < 0.05). Conclusion The recombinant Ad-Rb94 transfection combined with radiation shows synergism for the suppression of colorectal cancer cells growth. Retard the cell in G2 phase and promote cells apoptosis is may be the main mechanism. -
Key words:
- Gene, retinoblastoma 94 /
- Gene therapy /
- Radiotherapy /
- Colorectal neoplasms /
- Adenovirus
-
-
[1] Ganapathi S, Kumar D, Katsoulas N, et al. Colorectal cancer in the young: trends, charactistics and outcome[J]. Int J Colorectal, 2011, 26(7): 927-934. [2] 李进, 王芹, 宋力, 等.采用GatewayTM系统构建人Rb94基因重组腺病毒载体[J].肿瘤防治研究, 2010, 37(9): 1-5.
[3] Lamber EP, Beuron F, Morris EP, et al. Structural insights into the mechanism of phosphoregulation of the retinoblastoma protein[J/OL]. PLoS One, 2013, 8(3): e58463[2013-11-01]. http://www.ncbi.nlm.nih.gov/pubmed/23516486. [4] Zhang H, Li J, Wang YY, et al. Retinoblastoma 94 enhances radiation treatment esophageal squamous cell carcinoma in vitro and in vivo[J]. J Riat Res, 2012, 53(1): 117-124. [5] Araki K, Ahmad SM, Li G, et al. Retinoblastoma RB94 enhances radiation treatment of head and neck squamous cell carcinoma[J]. Clin Cancer Res, 2008, 14(11): 3514-3519. [6] Li D, Day KV, Yu S, et al. The role of adenovirus-mediated retinoblastoma 94 in the treatment of head and neck cancer[J]. Cancer Res, 2002, 62(16): 4637-4644. [7] Roig JM, Molina MA, Cascante A, et al. Adenovirus-mediated retinoblastoma 94 gene transfer induces human pancreatic tumor regression in a mouse xenograft model[J]. Clin Cancer Res, 2004, 10(4): 1454-1462. [8] Weichselbaum RR, Hallahan DE, Sukhatme VP, et al. Gene therapy targeted by ionizing radiation[J]. Int J Radiat Oncol Biol Phys, 1992, 24(3): 565-567. [9] 张耀文, 李进, 王芹, 等.基因治疗联合放射治疗恶性肿瘤的研究进展[J].国际放射医学核医学杂志, 2008, 32(4): 247-250.
[10] 陈凤华, 李进, 宋力, 等. Ad-Rb94基因联合γ射线对食管癌细胞生长的影响[J].国际放射医学核医学杂志, 2010, 34(2): 119-121.
[11] 王芹, 刘晓秋, 李进, 等.白细胞介素21基因联合不同剂量γ射线照射对乳腺癌细胞生长的影响[J].国际放射医学核医学杂志, 2012, 36(2): 94-96.
[12] Okamura K, Miki D, Nohara K. Inorganic arsenic exposure induces E2F-dependent G0/G1 arrest via an increase in retinoblastoma family protein p130 in B-cell lymphoma A20 cells[J]. Genes Cells, 2013, 18(10): 839-849. [13] Naderi S, Hunton IC, Wang JY. Radiation dose-dependent maintenance of G(2)arrest requires retinoblastoma protein[J]. Cell Cycle, 2002, 1(3): 193-200. [14] Pawlik TM, Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy[J]. Int J Radiat Oncol Biol Phys, 2004, 59(4): 928-942.